SIMPONI ARIA (also known as Golimumab)
Simponi aria is an antibody that block tumor necrosis factor alpha (TNFα) which is a core inflammatory modulator.
- Active, moderate-to-severe Rheumatoid Arthritis in conjunction with methotrexate
- Active Psoriatic Arthritis
- Active Ankylosing Spondylitis
Patients with active infection should not be started on Simponi aria. Patients with Hepatitis B and congestive heart failure should consult with their physicians prior to starting on Simponi Aria.
Simponi is typically administered as an infusion over thirty minutes at weeks 0, 4, and then every 8 weeks thereafter.